Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Gas Inhalation Linked to Reduced Heart Damage in Kawasaki Disease Mice

Hydrogen Gas Inhalation Treatment for Coronary Artery Lesions in a Kawasaki Disease Mouse Model

Research hubs: Cardiovascular System · Immune System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Hydrogen Gas Inhalation Treatment for Coronary Artery Lesions in a Kawasaki Disease Mouse Model
Evidence type
Animal study (mouse)
Authors
Wen-Ling Shih, Tsung-Ming Yeh, Kuang-Den Chen, Steve Leu, Shih-Feng Liu, Ying-Hsien Huang, Ho-Chang Kuo
Journal
Life
Year
2024
Study Type
Mouse
Delivery
Has
Duration
4 weeks
Outcome
Positive
Peer Reviewed
Yes
Cited by
3 (OpenAlex, as of November 2026)
Country
Taiwan

TL;DR

Inhaling hydrogen gas reduced heart artery swelling and inflammation in mice with a disease similar to Kawasaki disease in children.

Key Finding

Inhaled hydrogen gas significantly reduced coronary artery dilatation and decreased inflammatory markers (IL-6) in a mouse model of Kawasaki disease.

Summary

Kawasaki disease is a serious condition in young children that causes inflammation of blood vessels, particularly in the heart's coronary arteries. This study tested whether breathing hydrogen gas could help treat coronary artery damage in mice engineered to have Kawasaki disease. Researchers found that hydrogen gas inhalation reduced the abnormal widening of coronary arteries and lowered inflammatory markers (IL-6) in treated mice compared to untreated mice.

Practical Takeaway

This is early-stage research in mice only, so it does not yet show whether hydrogen gas would work in children with Kawasaki disease. The findings suggest hydrogen's antioxidant properties may help reduce inflammation and vessel damage, but human clinical trials would be needed to determine if this approach is safe and effective for actual patients.

Abstract (excerpt)

Background: Kawasaki disease (KD) is a syndrome primarily affecting young children, typically under the age of five, and is characterized by the development of acute vasculitis. Through extensive research conducted on both murine and human subjects, it has been demonstrated that heightened levels…

Read the full abstract on PubMed